clindamycin hydrochloride- clindamycin hydrochloride capsule
bryant ranch prepack - clindamycin hydrochloride (unii: t20oq1yn1w) (clindamycin - unii:3u02el437c) - clindamycin is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of colitis, as described in the boxed warning , before selecting clindamycin, the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). anaerobes: serious respiratory tract infections such as empyema, anaerobic pneumonitis, and lung abscess; serious skin and soft tissue infections; septicemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastrointestinal tract); infections of the female pelvis and genital tract such as endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis, and postsurgical vaginal cuff infection. streptococci: serious respiratory tract infections; serious skin and soft tissue infections. staphylococci: serious respiratory tract infections; serious skin and soft tissue infections. pneumococci: serious respiratory tract infections. bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin. to reduce the development of drug-resistant bacteria and maintain the effectiveness of clindamycin hydrochloride capsules usp and other antibacterial drugs, clindamycin hydrochloride capsules usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. clindamycin hydrochloride is contraindicated in individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin.
minoxidil tablet
bryant ranch prepack - minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1) - because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs. at the present time use in milder degrees of hypertension is not recommended because the benefit-risk relationship in such patients has not been defined. minoxidil reduced supine diastolic blood pressure by 20 mmhg or to 90 mmhg or less in approximately 75% of patients, most of who had hypertension that could not be controlled by other drugs. minoxidil tablets are contraindicated in pheochromocytoma, because it may stimulate secretion of catecholamines from the tumor through its antihypertensive action. minoxidil is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
fluoxetine 20mg capsules
sun pharma uk ltd - fluoxetine hydrochloride - oral capsule - 20mg
simvastatin 10mg tablets
sun pharma uk ltd - simvastatin - oral tablet - 10mg
simvastatin 20mg tablets
sun pharma uk ltd - simvastatin - oral tablet - 20mg
simvastatin 40mg tablets
sun pharma uk ltd - simvastatin - oral tablet - 40mg
citalopram 10mg tablets
sun pharma uk ltd - citalopram hydrobromide - oral tablet - 10mg
citalopram 20mg tablets
sun pharma uk ltd - citalopram hydrobromide - oral tablet - 20mg
citalopram 40mg tablets
sun pharma uk ltd - citalopram hydrobromide - oral tablet - 40mg
fluconazole 50mg capsules
sun pharma uk ltd - fluconazole - oral capsule - 50mg